News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
881,059 Results
Type
Article (88625)
Company Profile (817)
Press Release (791585)
Multimedia
Podcasts (230)
Webinars (34)
Section
Business (233525)
Career Advice (4159)
Deals (39956)
Drug Delivery (172)
Drug Development (91627)
Employer Resources (207)
FDA (18529)
Job Trends (17474)
News (398566)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3045)
Academic (2)
Accelerated approval (50)
Adcomms (39)
Allergies (185)
Alliances (56987)
ALS (225)
Alzheimer's disease (1943)
Antibody-drug conjugate (ADC) (499)
Approvals (18817)
Artificial intelligence (818)
Autoimmune disease (320)
Automation (61)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (238)
Biotechnology (487)
Bladder cancer (197)
Brain cancer (81)
Breast cancer (796)
Cancer (6188)
Cardiovascular disease (529)
Career advice (3591)
Career pathing (49)
CAR-T (366)
CDC (75)
Celiac Disease (3)
Cell therapy (1024)
Cervical cancer (49)
Clinical research (78475)
Collaboration (2263)
Company closure (8)
Compensation (1434)
Complete response letters (102)
COVID-19 (3030)
CRISPR (119)
C-suite (1203)
Cystic fibrosis (164)
Data (8085)
Decentralized trials (3)
Denatured (87)
Depression (187)
Dermatology (89)
Diabetes (636)
Diagnostics (7518)
Digital health (61)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (397)
Drug pricing (244)
Drug shortages (39)
Duchenne muscular dystrophy (305)
Earnings (102365)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (137687)
Executive appointments (1162)
FDA (22417)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (35)
Funding (1857)
Gene editing (263)
Generative AI (87)
Gene therapy (831)
GLP-1 (1249)
Government (5544)
Grass and pollen (8)
Guidances (413)
Healthcare (21099)
HIV (89)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (102)
Immunology and inflammation (347)
Immuno-oncology (104)
Indications (192)
Infectious disease (3405)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (147)
Intellectual property (300)
Interviews (820)
IPO (17992)
IRA (61)
Job creations (5206)
Job search strategy (2870)
JPM (73)
Kidney cancer (22)
Labor market (112)
Layoffs (680)
Leadership (50)
Legal (10171)
Liver cancer (107)
Longevity (35)
Lung cancer (809)
Lymphoma (440)
Machine learning (64)
Management (66)
Manufacturing (1153)
MASH (205)
Medical device (15233)
Medtech (15361)
Mergers & acquisitions (23221)
Metabolic disorders (1697)
mRNA (249)
Multiple sclerosis (197)
NASH (24)
Neurodegenerative disease (472)
Neuropsychiatric disorders (125)
Neuroscience (3595)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5137)
Now hiring (79)
Obesity (822)
Opinion (367)
Ovarian cancer (227)
Pain (275)
Pancreatic cancer (315)
Parkinson's disease (389)
Partnered (39)
Patents (626)
Patient recruitment (702)
Peanut (67)
People (67768)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24251)
Phase 2 (34089)
Phase 3 (25636)
Pipeline (8935)
Policy (386)
Postmarket research (3558)
Preclinical (10924)
Press Release (72)
Prostate cancer (318)
Psychedelics (68)
Radiopharmaceuticals (352)
Rare diseases (1203)
Real estate (7458)
Recruiting (81)
Regulatory (30112)
Reports (77)
Research institute (2763)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (27)
RSV (98)
Schizophrenia (191)
Series A (315)
Series B (228)
Service/supplier (30)
Sickle cell disease (122)
Special edition (31)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4365)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (140)
Vaccines (1267)
Venture capital (123)
Weight loss (568)
Women's health (132)
Worklife (24)
Date
Today (158)
Last 7 days (889)
Last 30 days (3822)
Last 365 days (33004)
2026 (13408)
2025 (33226)
2024 (38124)
2023 (42564)
2022 (53928)
2021 (58721)
2020 (57664)
2019 (51336)
2018 (39119)
2017 (37189)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (391)
Arkansas (16)
Asia (52097)
Australia (9163)
California (13821)
Canada (3879)
China (1452)
Colorado (596)
Connecticut (611)
Delaware (423)
Europe (120127)
Florida (2046)
Georgia (450)
Hawaii (4)
Idaho (69)
Illinois (1179)
India (99)
Indiana (640)
Iowa (25)
Japan (555)
Kansas (141)
Kentucky (56)
Louisiana (46)
Maine (89)
Maryland (1686)
Massachusetts (10085)
Michigan (413)
Minnesota (770)
Mississippi (7)
Missouri (161)
Montana (37)
Nebraska (30)
Nevada (149)
New Hampshire (92)
New Jersey (3674)
New Mexico (34)
New York (3622)
North Carolina (1873)
North Dakota (11)
Northern California (6829)
Ohio (430)
Oklahoma (26)
Oregon (55)
Pennsylvania (2744)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (87)
South Dakota (2)
Southern California (5404)
Tennessee (218)
Texas (2235)
United States (49479)
Utah (413)
Vermont (1)
Virginia (359)
Washington D.C. (88)
Washington State (1135)
West Virginia (4)
Wisconsin (153)
Wyoming (2)
There are 881,059 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
May 15, 2026
·
14 min read
Press Releases
ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update
May 15, 2026
·
16 min read
Press Releases
Positive Interim Data from Cohorts 1 and 2 of Tenaya’s RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC
May 15, 2026
·
13 min read
Press Releases
Phase II Data from a Randomized Double-Blind Trial of Ligufalimab (Anti-CD47) Combination Therapy in Frontline AML Published at EHA 2026
May 15, 2026
·
5 min read
Press Releases
Ozelle Wins German Innovation Award Gold for Advancing the Fourth Generation of Hematology Analysis
May 15, 2026
·
2 min read
Regulatory
Future of Aardvark’s Prader-Willi drug in doubt as FDA slaps full hold on program
Aardvark Therapeutics had previously voluntarily suspended studies of ARD-101—and a related asset called ARD-201—after detecting anomalous echocardiographic readings in healthy volunteers that could indicate reduced heart efficiency.
May 15, 2026
·
2 min read
·
Tristan Manalac
Series B
CREATE jumps into CAR T competition with $122M series B
CREATE Medicines is working on a clinical-stage pipeline for cancer, while its autoimmune programs are still in preclinical testing.
May 15, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Gilead Prices $3 Billion of Senior Unsecured Notes
May 14, 2026
·
3 min read
Press Releases
Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet
May 14, 2026
·
2 min read
Press Releases
The ADDF Highlights Encouraging Progress Toward Targeting Multiple Alzheimer’s Pathologies in Biogen’s Phase 2 Tau Study
May 14, 2026
·
3 min read
1 of 88,106
Next
